Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti-TNF failure-getting closer to the truth. Authors' reply

Fulltext:
225268.pdf
Embargo:
until further notice
Size:
187.8Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2020Source
Alimentary Pharmacology & Therapeutics, 52, 7, (2020), pp. 1255-1256ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Gastroenterology
Journal title
Alimentary Pharmacology & Therapeutics
Volume
vol. 52
Issue
iss. 7
Page start
p. 1255
Page end
p. 1256
Subject
Radboudumc 5: Inflammatory diseases RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [227436]
- Electronic publications [107269]
- Faculty of Medical Sciences [86157]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.